UK Markets closed

OPKO Health, Inc. (0KCS.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
3.0000+0.0200 (+0.67%)
At close: 06:00PM BST
Full screen
Previous close2.9800
Bid0.0000 x N/A
Ask0.0000 x N/A
Day's range3.0000 - 3.0850
52-week range3.0000 - 3.0850
Avg. volumeN/A
Market cap1.422B
Beta (5Y monthly)1.86
PE ratio (TTM)25.42
EPS (TTM)0.1180
Earnings date26 Apr 2022 - 02 May 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Zacks

    OPKO Health (OPK) Post In-Line Q1 Earnings, Revenues Top

    OPKO Health's (OPK) first-quarter results benefit from continued strength in its Pharmaceuticals segment.

  • Motley Fool

    Why Opko Health Stock Is Jumping Today

    Shares of Opko Health (NASDAQ: OPK) were jumping 13.5% higher as of 12:31 p.m. ET on Tuesday. Opko also announced on Monday that it has acquired ModeX Therapeutics in an all-stock deal valued at $300 million. The acquisition of ModeX could be good for Opko over the long term.

  • Motley Fool

    Opko Health (OPK) Q1 2022 Earnings Call Transcript

    This is Yvonne Briggs with LHA. Thank you all for joining today's call to discuss OPKO Health's financial results for the first quarter of 2022, as well as the recently announced ModeX Therapeutics acquisition.